CINECA IRIS Institutional Research Information System

SOFFIETTI, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.033
AS - Asia 10.749
EU - Europa 9.866
SA - Sud America 1.850
AF - Africa 242
OC - Oceania 181
Continente sconosciuto - Info sul continente non disponibili 20
Totale 37.941
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.395
SG - Singapore 3.354
CN - Cina 3.258
IT - Italia 3.028
BR - Brasile 1.372
VN - Vietnam 1.014
IE - Irlanda 991
FR - Francia 978
DE - Germania 911
JP - Giappone 822
SE - Svezia 572
FI - Finlandia 568
KR - Corea 552
UA - Ucraina 548
ES - Italia 517
GB - Regno Unito 492
CA - Canada 411
HK - Hong Kong 343
IN - India 342
PL - Polonia 234
NL - Olanda 225
AU - Australia 170
AR - Argentina 135
AT - Austria 134
MX - Messico 134
BD - Bangladesh 131
RU - Federazione Russa 125
ID - Indonesia 122
CO - Colombia 117
TR - Turchia 106
TW - Taiwan 102
TH - Thailandia 93
CH - Svizzera 91
IQ - Iraq 89
BE - Belgio 82
IL - Israele 71
PK - Pakistan 59
EC - Ecuador 56
NO - Norvegia 53
ZA - Sudafrica 52
GR - Grecia 51
CL - Cile 45
RO - Romania 45
PE - Perù 43
SA - Arabia Saudita 41
MY - Malesia 38
PT - Portogallo 37
VE - Venezuela 34
JM - Giamaica 31
KE - Kenya 29
IR - Iran 27
PY - Paraguay 27
UZ - Uzbekistan 27
CZ - Repubblica Ceca 26
MA - Marocco 26
EG - Egitto 25
DK - Danimarca 23
PH - Filippine 22
JO - Giordania 21
LT - Lituania 18
UY - Uruguay 18
DZ - Algeria 17
SI - Slovenia 17
AE - Emirati Arabi Uniti 16
SN - Senegal 15
AZ - Azerbaigian 13
TN - Tunisia 13
RS - Serbia 12
BG - Bulgaria 11
EU - Europa 11
NG - Nigeria 11
GH - Ghana 10
LB - Libano 10
LU - Lussemburgo 10
NP - Nepal 10
NZ - Nuova Zelanda 10
PA - Panama 10
ET - Etiopia 9
HR - Croazia 9
HU - Ungheria 9
SK - Slovacchia (Repubblica Slovacca) 9
CR - Costa Rica 8
BY - Bielorussia 7
KW - Kuwait 7
LV - Lettonia 7
MO - Macao, regione amministrativa speciale della Cina 7
MU - Mauritius 7
OM - Oman 7
PS - Palestinian Territory 7
BA - Bosnia-Erzegovina 6
CI - Costa d'Avorio 6
CY - Cipro 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
SY - Repubblica araba siriana 6
AL - Albania 5
CU - Cuba 5
HN - Honduras 5
KZ - Kazakistan 5
AO - Angola 4
Totale 37.852
Salva come PNG Salva come JPEG
Città #
Singapore 1.836
Beijing 1.196
San Jose 988
Dublin 975
Ashburn 884
Chandler 862
Santa Clara 603
Fairfield 538
Houston 522
Milan 476
Medford 359
The Dalles 344
Torino 338
Wilmington 335
Villeurbanne 334
Princeton 312
Tokyo 300
Columbus 298
Woodbridge 290
Lauterbourg 274
Los Angeles 274
Jacksonville 265
Ho Chi Minh City 262
Ann Arbor 252
Redwood City 246
Hong Kong 237
Seoul 235
Hangzhou 234
Rome 229
Hanoi 222
Seattle 216
Helsinki 208
Nyköping 205
Cambridge 200
Dallas 197
Warsaw 194
Turin 181
Shanghai 175
Hefei 161
New York 159
Buffalo 142
Dong Ket 137
Pisa 137
Boston 135
Dearborn 125
Madrid 122
São Paulo 121
Guangzhou 111
Toronto 106
Munich 91
Vienna 82
Boardman 77
Amsterdam 76
Naples 72
Council Bluffs 70
Frankfurt am Main 70
Fremont 70
Jakarta 70
Chicago 65
Philadelphia 65
Nanjing 64
Verona 64
Bengaluru 62
Chengdu 61
Taipei 61
Norwalk 57
Redondo Beach 54
Nuremberg 53
Bogotá 51
San Diego 51
London 48
Atlanta 45
Bangkok 44
Phoenix 44
Bologna 43
Barcelona 42
Montreal 42
Wuhan 42
Sydney 40
Figino 38
Haiphong 38
Zhengzhou 38
Berlin 37
Belo Horizonte 35
Brooklyn 35
Florence 35
Shenyang 35
Jinan 34
Ottawa 34
Da Nang 33
Lima 33
Osaka 32
Istanbul 31
Miami 31
Mumbai 30
Rio de Janeiro 30
Orem 29
Curitiba 28
Paris 28
Washington 28
Totale 20.020
Salva come PNG Salva come JPEG
Nome #
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial 3.622
STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis article 1.944
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. 1.315
Epilepsy and brain tumors. 645
Targeted therapy in brain metastasis 504
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas 473
MGMT promoter methylation in plasma of glioma patients receiving temozolomide. 430
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 429
Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases 403
Anti-Angiogenic Approaches to Malignant Gliomas 300
Updates in the management of brain metastases 264
A prognostic gene expression signature in infratentorial ependymoma. 253
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas 246
La palliazione in radioterapia oncologica 238
Mechanisms and therapy for cancer metastasis to the brain 233
The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors 227
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma 226
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients 219
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas 219
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma 216
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target 207
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 198
Does valproic acid affect tumor growth and improve survival in glioblastomas? 196
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis 192
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer 192
Gliomi: monitoraggio dello stato di metilazione del gene MGMT nel DNA plasmatico dei pazienti sottoposti a chemioterapia con agenti alchilanti 185
Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma 183
Neoplasie del sistema nervoso centrale 183
Liquid biopsy in Central Nervous System metastases: a RANO review and proposals for clinical applications 179
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology) 178
Primitive cerebral melanoma: case report and review of the literature. 177
The Evolving Landscape of Brain Metastasis 176
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis 175
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study. 174
Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue. 170
The 2021 WHO classification of tumors of the central nervous system: A summary 170
Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring 164
Tumori cerebrali 161
Tissue alterations induced by radio- and chemotherapy in brain with malignant gliomas. 159
A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme 159
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. 156
Prognostic characterization of higher-grade meningiomas: A histopathological score to predict progression and outcome 155
Ependymoma: Evaluation and Management Updates 152
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study 149
Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor 149
Efficacy of radiation therapy for epileptic seizures of grade 2 and 3 gliomas: a retrospective study 148
Pathological prognostic markers in central nervous system solitary fibrous tumour/ hemangiopericytoma: Evidence from a small series 147
Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis? 146
EANO guidelines for the diagnosis and treatment of ependymal tumors. 146
Adverse effects of antiepileptic drugs in brain tumors: Preliminary data of a multi-institutional survey. Are new antiepileptic drugs less toxic? 144
A pathologic study of malignant gliomas operated after radio- and chemotherapy. 143
Impiego di temozolomide negli ependimomi intracranici recidivanti dell’adulto 143
Supratotal Resection of Glioblastoma: Is Less More? 142
Automatic segmentation and therapy follow-up of cerebral glioma in diffusion-tensor images 137
Molecularly based management of gliomas in clinical practice 137
Antiangiogenic therapy of brain tumors: The role of bevacizumab 136
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? 136
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma 135
Delayed adverse effects after irradiation of gliomas: clinicopathological analysis. 134
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism 133
Pathology of human malignant gliomas after radiation and chemotherapy. 132
Current clinical management of elderly patients with glioma 132
[Long-term results of the treatment of infantile medulloblastoma] 131
Review: Peering through a keyhole: liquid biopsy in primary and metastatic central nervous system tumours 131
Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2-Mutant Lower-Grade Glioma 130
Neoplastic meningitis: Clinico-diagnostic aspects [Meningite neoplastica: Aspetti clinico-diagnostici] 129
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper. 129
Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas 128
Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects 127
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments 126
TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis acting on infiltrating CD8+ T cells 123
On the nature of the so-called monstrocellular sarcoma of the brain. 123
Response assessment criteria for brain metastases: Proposal from the RANO group 123
Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. 123
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance 123
ADJUVANT WHOLE BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES-RESULTS OF THE EORTC 22952-26001 STUDY 122
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group 122
TRATTAMENTO DELLE METASTASI CEREBRALI 121
Is there a Role for Bevacizumab in Non-Glial Tumors? 120
Controversies in management of low-grade gliomas in light of new data from clinical trials. 120
[Chemotherapy of cerebral tumours: data on malignant gliomas (author's transl)] 120
NCOG-19. PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE INSTITUTIONAL SERIES OF 160 PATIENTS 120
Association between multiple sclerosis and oligodendroglioma. Case report. 119
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups 119
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. 117
Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas. 116
Paraneoplastic opsoclonus: a neuropathologic study of two cases. 116
Efficacy of topiramate in patients with gliomas 115
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. 115
Spinal melanocytoma with leptomeningeal spread and long survival following surgery and chemotherapy 115
Temozolomide in rare brain tumors of the adult: a prospective study. 114
Extent of surgery in low-grade gliomas: an old question in a new context. 114
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 114
[Angiographic vascular images in a case of anaplastic astrocytoma and a case of giant cell sarcoma treated with chemotherapy (proceedings)] 111
Chemotherapy 111
Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001. 111
Medulloblastoma in adults: an analysis of clinico-pathological, molecular and treatment factors 111
Use of Antidepressants and Risk of Incident Stroke: A Systematic Review and Meta-Analysis 109
Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance 108
High speed autoradiography on brain tissue sections. 108
Totale 23.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.241
article - articoli 0
book - libri 0
conference - conferenze 7.469
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.134 149 138 192 213 188 214 175 199 149 302 565 650
2022/20233.935 421 238 125 323 306 987 450 222 370 131 204 158
2023/20242.335 291 311 151 158 176 191 154 191 36 149 181 346
2024/20255.270 116 444 235 573 973 220 204 289 514 398 436 868
2025/202612.357 822 666 724 1.462 1.227 557 1.392 608 979 1.080 684 2.156
2026/2027196 196 0 0 0 0 0 0 0 0 0 0 0
Totale 38.903